FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
New Gurugram centre is India's first clinical Prevention Centre with 2 state of the art MRI machines and a capacity of 2000 scans a month
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Developed with Wondrlab India, the 10-episode series brings together healthcare experts, a cancer survivor, and filmmaker Amole Gupte to foster meaningful conversations
Findings show growing optimism across the pharma sector as dealmaking accelerates, innovation strengthens, and companies adapt to tariffs, pricing reforms, and looming patent expirations
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
Subscribe To Our Newsletter & Stay Updated